GlassScriptPhysician profile
Badar Siddiqui
NPI 1447679238
$10,348.01
in general payments reported to CMS, 2019-2025
21 companies · $9,084 in 2025
The $9,084 reported for 2025 was more than what 95% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.32 · 2020: $32.24 · 2022: $80.96 · 2023: $299 · 2024: $781 · 2025: $9,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,115 · Food and Beverage: $2,170 · Travel and Lodging: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,114.98 |
| Food and Beverage | $2,170.13 |
| Travel and Lodging | $879.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,977.33 | 2022-2025 | |
| Glaxosmithkline, LLC. | $529.50 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $236.29 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.28 | 2020-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $180.22 | 2025 | Airsupra, Breztri, Tezspire |
| Regeneron Healthcare Solutions, INC. | $176.48 | 2024-2025 | Dupixent |
| Baxter Healthcare | $154.66 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $130.47 | 2023-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $118.73 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Insmed, INC. | $108.25 | 2023-2025 | Arikayce |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| United Therapeutics Corporation | $89.35 | 2024-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $69.95 | 2023-2024 | Acthar |
| Genentech USA, INC. | $57.39 | 2019 | |
| Ani Pharmaceuticals, INC. | $44.90 | 2023 | Purified Cortrophin Gel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $41.36 | 2024 | Smartvest |
| Verona Pharma, INC. | $36.19 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $31.86 | 2024 | Glassia |
| Viatris Specialty LLC | $25.43 | 2025 | Yupelri |
| Grifols USA, LLC | $24.05 | 2025 | Prolastin-C Liquid |
| Amgen INC. | $17.33 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Badar Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.